Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Qliq365

Qliq365 is the white labelled SaaS version of the industry-leading Impetus InSite Platform® for advisory boards and working groups in the medical space. It’s now available for agency use!

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Creative and design, Digital communications, IT solutions, Marketing consultancies, Medical communications

- PMLiVE

Nmblr

From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.

View Profile

IT solutions

Company Details

Qliq365
20 Bay Street, 11th Floor, Toronto, Ontario, M5J 2N8, Canada
6476375758
Contact Qliq365
Website

 Latest Content from PMHub 

Innovative Trials suspends services in Russia in response to Ukraine war

Press Releases | March 31, 2022 | Innovative Trials

Kate Shaw, Founder & CEO of the leading patient recruitment organisation based in Letchworth (UK), on the current Russia-Ukraine situation.

Nucleus Global launches Chrysalis Medical Communications, the network’s newest agency brand in Europe, with a unifying mission

Press Releases | March 30, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, today launched Chrysalis in Europe with the mission of transforming medical communications together.Stuart Gilbert, Managing Director, said: “Chrysalis’s mission...

Improving diversity in clinical trial patient recruitment

White Papers and Resources | March 29, 2022 | Innovative Trials

A key requirement for clinical trials is to understand the effect of potential treatments on the patient populations that will benefit most. Despite this, many studies find diverse patient recruitment...

Nucleus X Consulting – where patient engagement meets strategic consultancy

Press Releases | March 29, 2022 | Nucleus Global

Nucleus X Consulting consists of an agile team of specialists that combine expertise in all aspects of patient engagement along with strategic consultancy in rare disease and early-phase medical commercialisation.We...

Could I have a word please…?

White Papers and Resources | March 29, 2022 | Dice Medical Communications

Just how important is hard hitting copy?

Learning to invest in doctors’ education

White Papers and Resources | March 28, 2022 | M3 (EU)

Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for...

Top 10 Tips for Running a Successful Virtual Event

Videos and Podcasts | March 24, 2022 | Impetus Digital

As I explored in a recent article previously published on Pharmaphorum, the ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as...

Removing Barriers to Pharmaceutical Accessibility & Affordability Worldwide

Videos and Podcasts | March 24, 2022 | Impetus Digital

Dr. Dhiren Thakker, Founding President and CEO at Med Aditus, shares his insights into how blockchain and other leading-edge technologies can help revolutionize pharmaceutical manufacturing in sub-Saharan Africa and globally....

The Eleven guide to NFTs

Press Releases | March 24, 2022 | 11 London

Non-Fungible Tokens (NFTs) have been making waves in the news lately, specifically around the millions of dollars being exchanged for unique digital art assets. Investors have been queuing up to...

Extraordinary lives: advancing change in rare diseases (Part 2)

Press Releases | March 24, 2022 | Lucid Group Communications Limited

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...